Skip to main content
. 2010 Jul 12;42(8):555–564. doi: 10.3858/emm.2010.42.8.056

Figure 4.

Figure 4

Rebamipide inhibits PLD activity in gastric cancer cells. AGS and MKN-1 cells were labeled with [3H] myristate for 12 h, treated with 5 mM of rebamipide for the indicated times after which the PLD activity was measured. Each value represents the mean ± S.D. of three independent experiments. *P < 0.05 versus non-treatment.